Years
2020
Categories
Authors
- Alpar Gul (1)
- Aslan Beste Tacal (1)
- Ayhan Fatma (1)
- Baltacıoğlu Begüm Su (1)
- Baltacıoğlu Begümsu (1)
- Başak Funda Eken (1)
- Budak Ersin (1)
- Canan Sercan Dogan (1)
- Destan Ebru (1)
- Dilbaz N esrin (1)
- Dogan Canan Sercan (1)
- Doğan Canan Sercan (1)
- Eken Başak Funda (1)
- Ekmekçi Rıdvan (1)
- Erensoy Habib (1)
- Ergüzel Türker Tekin (1)
- Gokten Emel Sari (1)
- Iliya Ibrahim Abdullahi (1)
- Kaman Tugba (1)
- Karagöz Esra (1)
- Karapınar Gözdem (1)
- Kazan Ozlem Kızılkurt (1)
- Korkut Ulucan (1)
- Kulacaoglu Filiz (1)
- Musa Sunday Abraham (1)
- Noyan C. Onur (1)
- Nzalak James Oliver (1)
- Polat Tolga (2)
- Sezgin Kapici (1)
- Tela dris Abdu (1)
- Timucin Ahmet Can (1)
- Tolga Polat (1)
- Tufan Ali Evren (1)
- Uckun Burcu (1)
- Ulucan Korkut (2)
- Yılmaz Özlem Özge (2)
- Çisem Şilar (1)
- Öz Pınar (1)
- Özlem Özge Yilmaz (1)
- Üstün Besti (1)
- İpek Yüksel Gözler (1)
- İz Filiz (1)
- Şılar Çisem (2)
ARTICLES
Review Article
DRUG INTERACTIONS BETWEEN COVID-19 AND PSYCHIATRIC MEDICATIONS: A MINI REVIEW
Turkish Title : DRUG INTERACTIONS BETWEEN COVID-19 AND PSYCHIATRIC MEDICATIONS: A MINI REVIEW
İz Filiz,Kulacaoglu Filiz
JNBS, 2020, 7(3), p:101-105
Coronavirus disease 2019 (COVID-19) has become a pandemic with 8.708.000 confirmed cases and, 461.715 death in the world until 21 June 2020. The SARS-CoV-2 virus which is an enveloped and single-stranded RNA virus belonging to Coronaviridea family causes multiple organ systems diseases such as respiratory, gastrointestinal, hepatic and neurological tracts in humans and, animals. With the rapid and global spread of COVID-19, the scientific authorities have developed treatment algorithms for COVID-19. Besides the supportive care, chloroquine, hydroxychloroquine, lopinavir/ritonavir, favipiravir, tocilizumab, azithromycin, vitamin C, Convalescent plasma therapy are frequently used off-label to treat COVID-19. For severe COVID-19 cases, US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) Remdesivir, which is the first drug to earn the title. COVID-19 treatment may cause many side effects and drug interactions. Psychiatric diseases are also chronic diseases and psychiatric drugs may have severe interactions with COVID-19 medications. Drug interactions with psychiatric medication and neuropsychiatric side effects should be considered within the action mechanism of COVID-19 treatments. Thus, In this review, we aimed to elucidate the interactions of COVID-19 medications with the antidepressants, antipsychotics and, the other psychotropic drugs that have been frequently used in psychiatric diseases. Chloroquine, hydroxychloroquine, azithromycin, ribavirin, lopinavir/ritonavir have interactions with psychiatric medications such as antidepressants, antipsychotics, anticonvulsants and, anxiolytics in terms of QTc interval prolongation, hepatotoxicity, myelosuppression, increased or decreased concentration of medications. Remdesivir has lower interactions with most of the psychiatric drugs except St John’s Wort and some anticonvulsants. However, favipiravir is considered as the COVID-19 medication which has lower interaction and side effects in combination with psychiatric medication. The use of tocilizumab is also safe with most of the psychiatric drugs and has a positive effect on depressive symptoms, although there is a risk of hepatotoxicity.
Coronavirus disease 2019 (COVID-19) has become a pandemic with 8.708.000 confirmed cases and, 461.715 death in the world until 21 June 2020. The SARS-CoV-2 virus which is an enveloped and single-stranded RNA virus belonging to Coronaviridea family causes multiple organ systems diseases such as respiratory, gastrointestinal, hepatic and neurological tracts in humans and, animals. With the rapid and global spread of COVID-19, the scientific authorities have developed treatment algorithms for COVID-19. Besides the supportive care, chloroquine, hydroxychloroquine, lopinavir/ritonavir, favipiravir, tocilizumab, azithromycin, vitamin C, Convalescent plasma therapy are frequently used off-label to treat COVID-19. For severe COVID-19 cases, US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) Remdesivir, which is the first drug to earn the title. COVID-19 treatment may cause many side effects and drug interactions. Psychiatric diseases are also chronic diseases and psychiatric drugs may have severe interactions with COVID-19 medications. Drug interactions with psychiatric medication and neuropsychiatric side effects should be considered within the action mechanism of COVID-19 treatments. Thus, In this review, we aimed to elucidate the interactions of COVID-19 medications with the antidepressants, antipsychotics and, the other psychotropic drugs that have been frequently used in psychiatric diseases. Chloroquine, hydroxychloroquine, azithromycin, ribavirin, lopinavir/ritonavir have interactions with psychiatric medications such as antidepressants, antipsychotics, anticonvulsants and, anxiolytics in terms of QTc interval prolongation, hepatotoxicity, myelosuppression, increased or decreased concentration of medications. Remdesivir has lower interactions with most of the psychiatric drugs except St John’s Wort and some anticonvulsants. However, favipiravir is considered as the COVID-19 medication which has lower interaction and side effects in combination with psychiatric medication. The use of tocilizumab is also safe with most of the psychiatric drugs and has a positive effect on depressive symptoms, although there is a risk of hepatotoxicity.
Original Article
Turkish Title : EVALUATION OF THE EFFECTS OF LACTATIONAL EXPOSURE TO HYOSCYAMINE FRACTION OF DATURA STRAMONIUM L. SEEDS ON LEARNING AND MEMORY IN WISTAR RATS (RATTUS NORVEGICUS)
Tela dris Abdu,Musa Sunday Abraham,Iliya Ibrahim Abdullahi,Nzalak James Oliver
JNBS, 2020, 7(3), p:106-114
The study was designed to determine whether lactational exposure to hyoscyamine fraction of Datura stramonium L. (D. stramonium) seeds affect the cognitive, spatial learning and memory functions of the hippocampus in Wistar rats at adulthood. Fresh seeds of D. stramonium L. were procured, macerated and fractionated using high-performance liquid chromatography (HPLC). Eight (8) Wistar rats weighed 150-250 grams of equal gender were used for the study. The rats were mated and divided into control and treatment groups. Equivalent body weight of normal saline and 400 mg/kgbwt of hyoscyamine fraction were orally administered to the breastfeeding rats respectively on lactational days (LD) 1-21. At adulthood, the rats were subjected to neurobehavioural tests using novel objects recognition (NORT) and Morris water maze (MWM) respectively. The data obtained were expressed as mean ± SEM, independent two samples t-test and General Linear Model (GLM) repeatedmeasures ANOVA with Fisher’s multiple comparisons post-hoc tests were used to show the mean differences using Minitab 17 (LLC., U.K.) statistical package software. P < 0.05 was considered statistically significant. A significant increase in the meantime of exploration between the groups (p = 0.049) was observed during the NORT. No statistically significant increase (p = 0.626) in the meantime to locate the escape platform between the groups during the MWM test. The CA1 region of the treated group showed mild nuclear hyperchromasia, cytoplasmic vacuolations and pyknosis. In conclusion, exposure to hyoscyamine fraction of D. stramonium L. seeds at lactation caused histologic changes in the CA1 region, loss in short-term memory but not spatial learning and memory functions of the hippocampus of Wistar rats at adulthood.
The study was designed to determine whether lactational exposure to hyoscyamine fraction of Datura stramonium L. (D. stramonium) seeds affect the cognitive, spatial learning and memory functions of the hippocampus in Wistar rats at adulthood. Fresh seeds of D. stramonium L. were procured, macerated and fractionated using high-performance liquid chromatography (HPLC). Eight (8) Wistar rats weighed 150-250 grams of equal gender were used for the study. The rats were mated and divided into control and treatment groups. Equivalent body weight of normal saline and 400 mg/kgbwt of hyoscyamine fraction were orally administered to the breastfeeding rats respectively on lactational days (LD) 1-21. At adulthood, the rats were subjected to neurobehavioural tests using novel objects recognition (NORT) and Morris water maze (MWM) respectively. The data obtained were expressed as mean ± SEM, independent two samples t-test and General Linear Model (GLM) repeatedmeasures ANOVA with Fisher’s multiple comparisons post-hoc tests were used to show the mean differences using Minitab 17 (LLC., U.K.) statistical package software. P < 0.05 was considered statistically significant. A significant increase in the meantime of exploration between the groups (p = 0.049) was observed during the NORT. No statistically significant increase (p = 0.626) in the meantime to locate the escape platform between the groups during the MWM test. The CA1 region of the treated group showed mild nuclear hyperchromasia, cytoplasmic vacuolations and pyknosis. In conclusion, exposure to hyoscyamine fraction of D. stramonium L. seeds at lactation caused histologic changes in the CA1 region, loss in short-term memory but not spatial learning and memory functions of the hippocampus of Wistar rats at adulthood.
Original Article
Turkish Title : COMPUTATIONAL MODELLING OF TRANS-ZEATIN AS A NOVEL TARGET OF ADENOSINE A2A RECEPTOR: INSIGHTS INTO MOLECULAR INTERACTIONS
Destan Ebru,Öz Pınar,Timucin Ahmet Can
JNBS, 2020, 7(3), p:115-124
Adenosine A2A receptor (A2AR) is a G-protein coupled receptor that is involved in various physiological functions. Zeatin, a plant cytokinin and a derivative of adenine, is recently identified as new ligand of A2AR. However, the ligand-receptor interaction mechanism is not fully revealed. Here, we report a model structure of A2AR in complex with zeatin for the first time, to provide a better understanding of this interaction mechanism. A model structure of A2AR in complex with caffeine used as a positive control. As a result, zeatin displayed the ability to stay more stable at the binding pocket compared with caffeine and the residues involved in the interaction are identified. We propose that zeatin is indeed a novel and promising target for A2AR
Adenosine A2A receptor (A2AR) is a G-protein coupled receptor that is involved in various physiological functions. Zeatin, a plant cytokinin and a derivative of adenine, is recently identified as new ligand of A2AR. However, the ligand-receptor interaction mechanism is not fully revealed. Here, we report a model structure of A2AR in complex with zeatin for the first time, to provide a better understanding of this interaction mechanism. A model structure of A2AR in complex with caffeine used as a positive control. As a result, zeatin displayed the ability to stay more stable at the binding pocket compared with caffeine and the residues involved in the interaction are identified. We propose that zeatin is indeed a novel and promising target for A2AR
Original Article
Turkish Title : THE RELATIONSHIP BETWEEN THE VISUAL-SPATIAL PERCEPTIONS AND FACE RECOGNITION SKILLS IN PARENTS OF THE CHILDREN WITH AUTISM SPECTRUM DISORDER
Gokten Emel Sari,Uckun Burcu,Budak Ersin,Tufan Ali Evren
JNBS, 2020, 7(3), p:125-132
The aim of this study is to examine the correlation between the autism symptoms of children with Autism Spectrum Disorder and the visual-spatial perceptions and face recognition skills of the parents of these children. In the study, the parents of 30 children (30 mothers, 30 fathers) diagnosed with Intellectual Developmental Disorder and the parents of 30 children (30 mothers, 30 fathers) without any psychiatric disorder, totally 180 people, were assessed in order to compare the data of the parents of 30 children (30 mothers, 30 fathers) diagnosed with Autism Spectrum Disorder. Autism Behavior Checklist (ABC) was used in order to assess the symptoms of the children diagnosed with Autism Spectrum Disorder. Benton’s Judgment of Line Orientation Test (BJLO), Benton Facial Recognition Test (BFRT), and Symptom Checklist (SCL-90) were used in order to assess the parents in three groups. It was found that there was no correlation between the autism symptoms of the children diagnosed with Autism Spectrum Disorder and the visual-spatial perceptions and face recognition skills of their parents. The spatial perception skills of the fathers in the Autism Spectrum Disorder group were higher compared to the mothers in this group (p<0.001), it was found that the 14.4% (p=0.022) of the BFRT scores of the fathers in the Autism Spectrum Disorder and 11.8% (p=0.035) of the BFRT scores of the fathers in the Intellectual Developmental Disorder group were explained by the BJLO scores. It may be useful to focus on the gender, face recognition skill and the visual-spatial perception performance when researching the genetical aspects of the face processing disorder seen as consistent information in the Autism Spectrum Disorder phenotype
The aim of this study is to examine the correlation between the autism symptoms of children with Autism Spectrum Disorder and the visual-spatial perceptions and face recognition skills of the parents of these children. In the study, the parents of 30 children (30 mothers, 30 fathers) diagnosed with Intellectual Developmental Disorder and the parents of 30 children (30 mothers, 30 fathers) without any psychiatric disorder, totally 180 people, were assessed in order to compare the data of the parents of 30 children (30 mothers, 30 fathers) diagnosed with Autism Spectrum Disorder. Autism Behavior Checklist (ABC) was used in order to assess the symptoms of the children diagnosed with Autism Spectrum Disorder. Benton’s Judgment of Line Orientation Test (BJLO), Benton Facial Recognition Test (BFRT), and Symptom Checklist (SCL-90) were used in order to assess the parents in three groups. It was found that there was no correlation between the autism symptoms of the children diagnosed with Autism Spectrum Disorder and the visual-spatial perceptions and face recognition skills of their parents. The spatial perception skills of the fathers in the Autism Spectrum Disorder group were higher compared to the mothers in this group (p<0.001), it was found that the 14.4% (p=0.022) of the BFRT scores of the fathers in the Autism Spectrum Disorder and 11.8% (p=0.035) of the BFRT scores of the fathers in the Intellectual Developmental Disorder group were explained by the BJLO scores. It may be useful to focus on the gender, face recognition skill and the visual-spatial perception performance when researching the genetical aspects of the face processing disorder seen as consistent information in the Autism Spectrum Disorder phenotype
Original Article
DETERMINATION OF THE ANXIETY – RELATED SLC6A4 GENE PROMOTER “S” AND “L” ALLELES IN FOOTBALL PLAYERS
Turkish Title : DETERMINATION OF THE ANXIETY – RELATED SLC6A4 GENE PROMOTER “S” AND “L” ALLELES IN FOOTBALL PLAYERS
Özlem Özge Yilmaz,Tolga Polat,Çisem Şilar,İpek Yüksel Gözler,Sezgin Kapici,Canan Sercan Dogan,Başak Funda Eken,Korkut Ulucan
JNBS, 2020, 7(3), p:133-136
Original Article
DEVELOPMENT OF THE COVID-19 PHOBIA SCALE: VALIDITY AND RELIABILITY STUDY
Turkish Title : DEVELOPMENT OF THE COVID-19 PHOBIA SCALE: VALIDITY AND RELIABILITY STUDY
Dilbaz N esrin,Noyan C. Onur,Alpar Gul,Kazan Ozlem Kızılkurt
JNBS, 2020, 7(3), p:137-146
It is suggested that the psychological and emotional reactions that occurred during the COVID-19 pandemic may lead to serious psychiatric disorders in the long run. This study aims to establish the validity and reliability of the COVID-19 Phobia Scale developed for measuring emotions and behaviours related to the COVID-19 pandemic. The sociodemographic form, COVID-19 Phobia Scale developed by the researchers, Hospital Anxiety and Depression Scale, and Health Anxiety Scale were applied in the study conducted through a web-based survey method. An item-total analysis was performed as the first step of the study that was conducted with 1243 participants. The exploratory and confirmatory factor analyses revealed the final version of the COVID-19 Phobia Scale to comprise four subscales made up of 22 items, where the subscales were termed as Worry, Mood, Reassurance Seeking/Precaution and Avoidance. The internal consistency of the COVID-19 Phobia Scale measured by the Cronbach alpha coefficient was 0.84. A statistically significant positive correlation was found between the COVID-19 Phobia Scale and Hospital Anxiety and Depression Scale, Health Anxiety Scale. The COVID-19 Phobia Scale is a valid and reliable scale that can be used to measure emotions and related behavioural changes.
It is suggested that the psychological and emotional reactions that occurred during the COVID-19 pandemic may lead to serious psychiatric disorders in the long run. This study aims to establish the validity and reliability of the COVID-19 Phobia Scale developed for measuring emotions and behaviours related to the COVID-19 pandemic. The sociodemographic form, COVID-19 Phobia Scale developed by the researchers, Hospital Anxiety and Depression Scale, and Health Anxiety Scale were applied in the study conducted through a web-based survey method. An item-total analysis was performed as the first step of the study that was conducted with 1243 participants. The exploratory and confirmatory factor analyses revealed the final version of the COVID-19 Phobia Scale to comprise four subscales made up of 22 items, where the subscales were termed as Worry, Mood, Reassurance Seeking/Precaution and Avoidance. The internal consistency of the COVID-19 Phobia Scale measured by the Cronbach alpha coefficient was 0.84. A statistically significant positive correlation was found between the COVID-19 Phobia Scale and Hospital Anxiety and Depression Scale, Health Anxiety Scale. The COVID-19 Phobia Scale is a valid and reliable scale that can be used to measure emotions and related behavioural changes.
Original Article
Turkish Title : THE DISTRIBUTION OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) RS6265 POLYMORPHISM IN TURKISH VOLLEYBALL PLAYERS
Polat Tolga,Doğan Canan Sercan,Eken Başak Funda,Yılmaz Özlem Özge,Şılar Çisem,Karapınar Gözdem,Baltacıoğlu Begümsu,Ekmekçi Rıdvan,Ulucan Korkut
JNBS, 2020, 7(3), p:147-151
Athletic performance is associated with many environmental factors such as inborn genetic factors, nutrition, psychological factors, and education. We aimed to analyze the brain derived neurotrophic factor (BDNF) rs6265 polymorphism, which is an important genetic marker related to psychological factors, in 21 professional female volleyball players and compare it with the control group. Genotyping was assessed by Real-time PCR technique. BDNF rs6265 polymorphism genotypes were calculated as 72% and 28% for GG and GA in volleyball players, respectively. No AA genotype was detected. In the control group, the GG, GA and AA genotype percentages were calculated as 57.8, 36.3 and 5.9, respectively. In the allelic distribution, the percentages in the athlete group were calculated as 86% (36) for the G allele and 14% (6) for the A allele, respectively. In the control group, for the G and A alleles, respectively; it was 76.25% and 23.75%. No statistical significance was found in terms of both genotype distribution (p = 0.407) and allelic frequency distribution (p = 0.218). Our results were in line with data indicating the stress and anxiety-related nature of professional volleyball players. More studies with more athletes and more groups of athletes are needed to understand the effect of these parameters on volleyball players.
Athletic performance is associated with many environmental factors such as inborn genetic factors, nutrition, psychological factors, and education. We aimed to analyze the brain derived neurotrophic factor (BDNF) rs6265 polymorphism, which is an important genetic marker related to psychological factors, in 21 professional female volleyball players and compare it with the control group. Genotyping was assessed by Real-time PCR technique. BDNF rs6265 polymorphism genotypes were calculated as 72% and 28% for GG and GA in volleyball players, respectively. No AA genotype was detected. In the control group, the GG, GA and AA genotype percentages were calculated as 57.8, 36.3 and 5.9, respectively. In the allelic distribution, the percentages in the athlete group were calculated as 86% (36) for the G allele and 14% (6) for the A allele, respectively. In the control group, for the G and A alleles, respectively; it was 76.25% and 23.75%. No statistical significance was found in terms of both genotype distribution (p = 0.407) and allelic frequency distribution (p = 0.218). Our results were in line with data indicating the stress and anxiety-related nature of professional volleyball players. More studies with more athletes and more groups of athletes are needed to understand the effect of these parameters on volleyball players.
Original Article
THE DEVELOPMENT OF A FUZZY LOGIC MODEL-BASED SUICIDE RISK ASSESSMENT TOOL
Turkish Title : THE DEVELOPMENT OF A FUZZY LOGIC MODEL-BASED SUICIDE RISK ASSESSMENT TOOL
Ayhan Fatma,Üstün Besti,Ergüzel Türker Tekin
JNBS, 2020, 7(3), p:152-159
The purpose of the research was to develop a fuzzy logic model-based risk assessment tool and to determine the views of health professionals working in community mental health centers concerning this. A methodological method was employed in developing the fuzzy logic model-based risk assessment tool, and the qualitative research method was used to elicit attitudes toward it. In the first stage, the suicide risk assessment tool was developed. In second stage the health professionals used the suicide risk assessment tool for four weeks. Feedback regarding health professionals’ opinions of the suicide risk assessment tool was then elicited handling a semi-structured reportage form, and data were investigate handling descriptive analysis. Health professionals reported powerful aspects making the suicide risk assessment tool a functional, practical, comprehensive, and highly applicable guideline. Participants also recommended the addition to the results screen of a chart showing the course of the suicide risk assessment, and that the reliability and validity of the tool be confirmed. In conclusion, health professionals expressed positive opinions regarding the scope of the suicide risk assessment tool and its measurement of that risk. Following confirmation of its reliability and validity, it may be useful for the fuzzy logic-based suicide risk assessment form to be integrated into and applied in the community health centers system.
The purpose of the research was to develop a fuzzy logic model-based risk assessment tool and to determine the views of health professionals working in community mental health centers concerning this. A methodological method was employed in developing the fuzzy logic model-based risk assessment tool, and the qualitative research method was used to elicit attitudes toward it. In the first stage, the suicide risk assessment tool was developed. In second stage the health professionals used the suicide risk assessment tool for four weeks. Feedback regarding health professionals’ opinions of the suicide risk assessment tool was then elicited handling a semi-structured reportage form, and data were investigate handling descriptive analysis. Health professionals reported powerful aspects making the suicide risk assessment tool a functional, practical, comprehensive, and highly applicable guideline. Participants also recommended the addition to the results screen of a chart showing the course of the suicide risk assessment, and that the reliability and validity of the tool be confirmed. In conclusion, health professionals expressed positive opinions regarding the scope of the suicide risk assessment tool and its measurement of that risk. Following confirmation of its reliability and validity, it may be useful for the fuzzy logic-based suicide risk assessment form to be integrated into and applied in the community health centers system.
Original Article
VITAMIN B12 AND FOLIC ACID IN DEPRESSION AND ANXIETY: A PILOT STUDY
Turkish Title : VITAMIN B12 AND FOLIC ACID IN DEPRESSION AND ANXIETY: A PILOT STUDY
Erensoy Habib
JNBS, 2020, 7(3), p:160-165
The association between nutrition and mental diseases has been extensively studied. Vitamin B12 and folic acid are the main vitamins in the development of the central nervous system. This study aimed to investigate the relationship between vitamin B12 and folic acid levels with depression and anxiety. A total of 150 patients (77 with anxiety and 73 with depression) between 18 and 79 were enrolled. The initial mood state was evaluated using Beck’s Depression Inventory-II (BDI-II) and Beck’s Anxiety Inventory (BAI) for the presence of depression and anxiety, respectively. Venous blood samples were collected after overnight fasting and vitamin B12 and folic acid levels were measured. Serum concentrations of folic acid were significantly lower in patients with depression than those with anxiety (p=0.04). Substantially higher vitamin B12 levels were described in men than females counterparts with severe depression (p=0.049). Additionally, there was a significant inverse correlation between folic acid levels and Beck’s inventory score among patients with severe depression (r=-0.250, p=0.049). Serum levels of vitamin B12 and folic acid could be used as markers that assess anxiety and depression’s therapeutic efficiency.
The association between nutrition and mental diseases has been extensively studied. Vitamin B12 and folic acid are the main vitamins in the development of the central nervous system. This study aimed to investigate the relationship between vitamin B12 and folic acid levels with depression and anxiety. A total of 150 patients (77 with anxiety and 73 with depression) between 18 and 79 were enrolled. The initial mood state was evaluated using Beck’s Depression Inventory-II (BDI-II) and Beck’s Anxiety Inventory (BAI) for the presence of depression and anxiety, respectively. Venous blood samples were collected after overnight fasting and vitamin B12 and folic acid levels were measured. Serum concentrations of folic acid were significantly lower in patients with depression than those with anxiety (p=0.04). Substantially higher vitamin B12 levels were described in men than females counterparts with severe depression (p=0.049). Additionally, there was a significant inverse correlation between folic acid levels and Beck’s inventory score among patients with severe depression (r=-0.250, p=0.049). Serum levels of vitamin B12 and folic acid could be used as markers that assess anxiety and depression’s therapeutic efficiency.
Original Article
DISTRIBUTION OF DOPAMINE RECEPTOR 2 (DRD2) RS1800497 POLYMORPHISMS IN PROFESSIONAL CYCLIST
Turkish Title : DISTRIBUTION OF DOPAMINE RECEPTOR 2 (DRD2) RS1800497 POLYMORPHISMS IN PROFESSIONAL CYCLIST
Karagöz Esra,Şılar Çisem,Yılmaz Özlem Özge,Polat Tolga,Aslan Beste Tacal,Baltacıoğlu Begüm Su,Dogan Canan Sercan,Kaman Tugba,Ulucan Korkut
JNBS, 2020, 7(3), p:166-169
Genetic and environmental factors are important determinants of the athletic performance. Sports genetic determines certain the alleles for the identification of the genes that affect athletic performance. Comprehensive researches, including the biology of mental properties are accumulating due to the improvement of the information of molecular biology. Dopamine is an important neurotransmitter of the dopaminergic system that affects the athlete mentally and psychologically. In this study, our goal is to determine the genotype and allele distributions of the DRD2 rs180047 polymorphism in the cyclists. 19 cyclists and 52 sedentary individuals (controls) participated in our study. Genotyping was carried out by real time PCR (rt-PCR) after DNA was isolated from buccal epithelial cells. In our cohort, AG and GG genotypes were detected as 6 (32%) and 13 (68%), respectively. In the control group, the respective AA, AG and GG genotypes were detected as 9 (17%), 18 (35%) and 25 (48%). No statistically significant difference was detected in terms of genotype distribution between the two groups (p= 0,1107). When allelic distributions were examined, in athlete cohort. A and G allele numbers were counted as 6 (16%) and 32 (84%), respectively. In the control group, same alleles were count as 36 (35%) and 68 (65%). There was no significant difference in the terms of alleles in our study cohort (p=0,0295). In our cohort, GG genotype and the G allele of the DRD2 rs1800497 polymorphism were dominant. Recent studies showed the association of the A allele with addiction. Therefore we hypothesized the association of the related allele and sucess in cyclists. Although we were unable to find statistically significant difference, we suggest to analyse the same polymorphism in athletes with different sport branches to fulfill the role of the given polymorphism.
Genetic and environmental factors are important determinants of the athletic performance. Sports genetic determines certain the alleles for the identification of the genes that affect athletic performance. Comprehensive researches, including the biology of mental properties are accumulating due to the improvement of the information of molecular biology. Dopamine is an important neurotransmitter of the dopaminergic system that affects the athlete mentally and psychologically. In this study, our goal is to determine the genotype and allele distributions of the DRD2 rs180047 polymorphism in the cyclists. 19 cyclists and 52 sedentary individuals (controls) participated in our study. Genotyping was carried out by real time PCR (rt-PCR) after DNA was isolated from buccal epithelial cells. In our cohort, AG and GG genotypes were detected as 6 (32%) and 13 (68%), respectively. In the control group, the respective AA, AG and GG genotypes were detected as 9 (17%), 18 (35%) and 25 (48%). No statistically significant difference was detected in terms of genotype distribution between the two groups (p= 0,1107). When allelic distributions were examined, in athlete cohort. A and G allele numbers were counted as 6 (16%) and 32 (84%), respectively. In the control group, same alleles were count as 36 (35%) and 68 (65%). There was no significant difference in the terms of alleles in our study cohort (p=0,0295). In our cohort, GG genotype and the G allele of the DRD2 rs1800497 polymorphism were dominant. Recent studies showed the association of the A allele with addiction. Therefore we hypothesized the association of the related allele and sucess in cyclists. Although we were unable to find statistically significant difference, we suggest to analyse the same polymorphism in athletes with different sport branches to fulfill the role of the given polymorphism.
ISSN (Print) | 2149-1909 |
ISSN (Online) | 2148-4325 |
2020 Ağustos ayından itibaren yalnızca İngilizce yayın kabul edilmektedir.